by long, periods of severe hypoglycemia caused by impaired glucagon secretion. 1, 4, [5] [6] [7] [8] Possible etio logical mechanisms of diabetes secondary to chronic pancreatitis are listed in When discussing insulin resistance, meta bolic syndrome (also known as insulin resistance syndrome) should be mentioned. It is not considered as a separate disease entity, but rather as a cluster of risk factors for cardiovascular disease and type 2 diabetes. Metabolic syndrome includes abdominal obesity, elevated blood pressure, high triglyceride levels, low high-density lipoprotein (HDL) cholesterol levels, and impaired fasting plasma glucose. Prior diagnosis and treatment of diabetes, hypertension, or dyslipidemia allows to establish the presence of a particular risk factor. The comparison of 2 existing definitions of meta bolic syndrome, the one published in 2001 by the Adult Treatment Panel III (ATP III) and a newer one, developed in 2005 by the International Diabetes Federation (IDF), reveals differences in the criteria used to assess abdominal obesity and fasting glucose levels (TAbLE 2). The updated 2005 definition includes the race factor and identifies abdominal obesity as the waist circumference of at least 80 cm for women and 94 cm for men, as compared with 88 and 102 cm, respectively, in the ATP III guidelines. It seems that abdominal obesity, and not the total body fat, plays the most important role in the development of insulin resistance. As obesity becomes increasingly widespread, meta bolic syndrome may emerge as the most common clinical syndrome associated with insulin resistance. [9] [10] [11] [12] [13] [14] The aim of the study was to determine insulin resistance in patients with chronic alcoholic pancreatitis using the euglycemic clamp method. Insulin resistance was assessed in the context of abdominal obesity, coexistent dyslipidemia and hypertension, as well as various carbohydrate metabolism disturbances.
PATIENTs ANd mEThOds A total of 30 patients diagnosed with chronic pancreatitis with or without carbohydrate meta bolism disturbances were included in the study. Chronic pancreatitis had been previously diagnosed on the basis of ultrasonography or computed tomography. Morphological stage of the disease was evaluated on the basis of the widely accepted Cambridge classification. Functional and bio chemical tests (e.g., elastase 1) were not performed, because of their overall negative effect on the body and limited usefulness in this particular study. All patients were supplemented with pancreatic enzymes, and at the time of the study, they did not report symptoms characteristic of the failure of pancreatic exocrine cells (steatorrhea, progressive weight loss). Diabetes had been previously diagnosed and treated in 20 of 30 patients (66.66%), a proportion reflecting preexisting epidemio logical data. Characteristics of the patients are presented in In patients with chronic pancreatitis and normal carbohydrate meta bolism, an oral glucose tolerance test was performed after a challenge with 75 g of glucose. 15 Sensitivity to insulin was determined using the euglycemic clamp, which is a well-established reference method. 16 It is used to determine tissue consumption of glucose in response to artificially induced insulinemia. Under conditions of constant hyperinsulinemia, the amount of glucose utilized by tissues equals the amount of infused exogenic glucose, because after the first hour, the production of endogenous glucose becomes fully suppressed.
The test was performed using the TISS system developed in the Institute of Biostructure and Biocybernetics of the Polish Academy of Sciences in Warsaw, Poland. Normal tissue glucose utilization (TGU) was determined as higher than 5 mg/kg body weight/min on the basis of a test performed in healthy subjects in the past. 17 In our study, we decided not to perform the test for comparison either in healthy controls or patients with meta bolic syndrome, because of its overall negative effect on the body. We agreed that the previously obtained results using the same system were sufficient to establish normal TGU values (an example of normal results is given in FIGuRE 1).
Abdominal obesity was assessed using several anthropometric para meters, such as waist circumference (WC), inter preted according to the 2005 IDF guidelines, waist-to-hip ratio (WHR), and a relatively new index of central obesity (ICO), also known as waist-to-height ratio (WHtR). WHR lower than 0.8 for men and 1.0 for women was considered normal.
18,19 ICO, or WHtR, is calculated according to the formula: WC (cm)/height (cm); the normal values are: <0.51 for men and <0.47 for women.
20,21 The BMI was calculated according to the formula: body weight (kg)/height (m 2 ), with normal values ranging from 20 to 25 kg/m 2 . [22] [23] [24] Statistical analysis was performed using the STATISTICA 8.0 software. The Student's t-test for independent samples was used to determine statistical significance (P <0.05 considered as statistically significant). The analysis of variance was used for nonnormal distribution, ordinal the study was described as pancreatic (secondary, other); the course of the disease in each patient is detailed in TAbLE 4.
Medical history was taken from all patients, and physical examination was performed, with an additional assessment of the oral cavity and detailed otolaryngo logical examination. Moreover, within 6 months prior to the study, all patients underwent imaging of the liver and pancreas (focal lesions, cirrhosis, etc.) as well as a number of bio chemical tests on admission (TAbLE 5) . This allowed to exclude conditions that might have affected insulin resistance, such as inflammation, liver cirrhosis, advanced renal and heart failure, unstable coronary disease, and neoplastic disease. long-term complication, n (%) 8 (40) coronary heart disease, n (%) 2 (10) cerebrovascular disease, n (%) 0 (0) peripheral artery disease, n (%) 2 (10) retinopathy, n (%) 1 (5) nephropathy, n (%) 0 (0) neuropathy, n (%) 2 (10) diabetic foot syndrome, n (%) 1 (5) Abbreviations: see (FIGuRE 3) . Also, there was no statistically significant correlation between WC and TGU. Of all anthropometric para meters, the ICO was most useful in assessing insulin resistance in patients with chronic pancreatitis. Significantly higher TGU was observed in patients with normal ICO compared with those with higher ICO (4.89 ±1.75 vs. 3.23 ±2.11 mg/kg/min, respectively; P = 0.02; FIGuRE 4). We did not observe any statistically significant differences in TGU when analyzing low and normal HDL cholesterol levels according to sex as well as increased and normal triglyceride levels, as recommended by the IFD in the diagnosis of meta bolic syndrome (FIGuREs 5 and 6).
Because insulin resistance is commonly associated with hypertension, TGU values in patients with and without hypertension were compared but no statistically significant differences were found (4.23 ±2.20 vs. 3.99 ±1.99 mg/kg/min, respectively; P = 0.75; FIGuRE 7).
Prior to the study, 20 of 30 patients were diagnosed with diabetes (diabetes subgroup); the remaining 10 patients underwent a 75 mg glucose challenge (using the oral glucose tolerance test [OGTT] ) that allowed to diagnose diabetes in 2 additional patients (newly diagnosed diabetes subgroup). The OGTT revealed prediabetes with impaired fasting glucose (IFG) in 4 patients (IFG subgroup), and normal carbohydrate metabolism (NCM) in 4 patients (NCM subgroup). All subgroups were compared with respect to their mean TGU. It was normal (>5 mg/kg/min) only in the NCM and IFG subgroups. The results are presented in FIGuRE 8. dIsCussION With the increasing occurrence of obesity, insulin resistance has become a particularly important issue, with the result of there being much discussion as to whether it is useful to diagnose meta bolic syndrome, which is an easy way to identify risk factors. Assessing insulin sensitivity, especially with the use of such a complicated and time-consuming method as the euglycemic clamp, is practically limited to scientific research. It is important to relate theses results to simple bio chemical assays used in everyday clinical practice. Use of the BMI in anthropometric assessment of insulin sensitivity is worth considering. This simple para meter has long provided a quick and effective way to diagnose overweight and obesity, even though new para meters, described above, have been introduced. 22-24 Our study showed a strong negative correlation between BMI and TGU (r = -0.33), and although the significance level was low (P = 0.07), this relationship should not be ignored (FIGuRE 2) .
WC is one of the meta bolic syndrome diagnostic criteria, and by many researchers it is considered as a requisite for determining insulin data, and variance heterogeneity. Normal distribution of the variables, i.e., determining whether a given para meter is randomly selected from the population characterized by normal distribution, was assessed using the Shapiro-Wilk, Kolmogorov-Smirnov, and Lilliefors tests. Correlations were analyzed using the Pearson test for normal and the Spearman test for nonnormal distribution.
25
REsuLTs Insulin resistance was diagnosed in 22 patients (73% of the study group). A comparison between patients with insulin resistance and patients with normal TGU is presented in There was a negative correlation between BMI and TGU that was close to the level of statistical significance (P = 0.07). Of note, normal TGU was observed in only 1 patient from the group of subjects with BMI >25 kg/m 2 (FIGuRE 2). Recently, a number of studies emphasized the important prognostic value of the ICO.
20,31
Our study showed statistically significantly higher mean TGU values in patients with normal ICO as compared with those with elevated ICO. It should be highlighted that of all analyzed para meters, resistance. [26] [27] [28] [29] [30] The comparison of TGU values between patients with normal WC and patients with abdominal obesity showed higher values in the first subgroup, although the differences were not statistically significant (4.51 ±2.21 mg/kg/min vs. 3.05 ±1.19 mg/kg/min; P = 0.08; FIGuRE 3). abnormalities in blood lipid levels, together with insulin resistance, are directly linked to a significant increase in cardiovascular risk associated with atherosclerosis, and therefore are referred to as "atherogenic dyslipidemia". [32] [33] [34] In our study, mean TGU values did not differ significantly between the subgroups of patients with chronic pancreatitis with low and normal HDL cholesterol and high and normal triglyceride levels (FIGuREs 5 and 6) . However, the results might have been biased by chronic pancreatitis only the ICO clearly showed a statistically significant correlation with TGU. Therefore, it may possibly become the most reliable, noninvasive indicator of insulin resistance in the future.
Dyslipidemia is one of the common features of meta bolic syndrome. Hypertriglyceridemia is the most typical type of dyslipidemia, and it has been shown to correlate with a decrease in insulin sensitivity and coexist with elevated levels of low-density lipoprotein cholesterol and decreased levels of HDL cholesterol. The above The analysis of the subgroups of patients characterized by various types of carbohydrate meta bolism disturbances revealed the lowest mean TGU values in the diabetes subgroup (3.73 ±2.10 mg/kg/min) and highest in the NCM subgroup (5.42 ±2.67 mg/kg/min). Intermediate values were observed in the newly diagnosed diabetes and IFG subgroups (FIGuRE 8) . It may suggest that lower insulin sensitivity can accompany other carbohydrate meta bolism disturbances present in chronic pancreatitis and act as an additional causative mechanism of these disturbances.
Conclusions
Insulin resistance is detected in almost 75% of patients with chronic pancreatitis, despite the lack of obesity diagnosed on the basis of the BMI.
The ICO seems to be the most reliable anthropometric para meter that allows to detect insulin resistance in patients with chronic pancreatitis. We did not observe any correlations between lipid meta bolism and insulin sensitivity. Coexistence of hypertension and chronic pancreatitis does not influence insulin resistance in any way. Lower insulin sensitivity, which is observed more often in patients with chronic pancreatitis and coexistent diabetes than in patients with normal carbohydrate meta bolism, may suggest that the occurrence of insulin resistance syndrome is one of the mechanisms leading to the development of pancreatic diabetes. and secondary disturbances of intestinal absorption resulting from impaired exocrine function.
Elevated blood pressure and/or previously diagnosed and treated hypertension are important components of meta bolic syndrome. The association between hypertension and insulin resistance results from increased activation of both the renin-angiotensin-aldosterone pathway and sympathetic nervous system. This, in turn, is caused by an increased para crine and endocrine activity of adipocytes in abdominal obesity as well as of secondary hyperinsulinemia.
35-38 We did not observe significant differences in the mean values of TGU between patients with hypertension and patients with normal blood pressure. Possibly, hypertension detected in this group of patients constitutes an independent, coexistent clinical disorder and is not a direct consequence of insulin resistance, as it was determined in the case of patients with dyslipidemia. 
